Mirati Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
71.31
|
|
Average Rating
|
3.82
|
|
# Strong Buys
|
5
|
|
# Buys
|
4
|
|
# Holds
|
8
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-3.48
|
-3.09
|
0.39
|
11.21%
|
|
2022-06-30
|
-3.49
|
-3.18
|
0.31
|
8.88%
|
|
2022-03-31
|
-3.49
|
-3.40
|
0.09
|
2.58%
|
|
2021-12-31
|
-3.00
|
-3.72
|
-0.72
|
-24.00%
|
|
2021-09-30
|
-2.89
|
-1.55
|
1.34
|
46.37%
|
|
2021-06-30
|
-2.40
|
-3.23
|
-0.83
|
-34.58%
|
|
2021-03-31
|
-2.13
|
-2.67
|
-0.54
|
-25.35%
|
|
2020-12-31
|
-2.23
|
-2.08
|
0.15
|
6.73%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-9.67
|
|
2021-12-31
|
-11.17
|
|
2020-12-31
|
-7.95
|
|
2019-12-31
|
-5.64
|
|
2018-12-31
|
-3.17
|
|
2017-12-31
|
-2.79
|
|
2016-12-31
|
-4.20
|
|
2015-12-31
|
-3.79
|
|
2014-12-31
|
-3.22
|
|
2013-12-31
|
-5.69
|
|
2012-12-31
|
-2.46
|